法国多中心回顾性研究:弯曲杆菌属所致血管感染与心内膜炎
该研究为法国全国性5年回顾性研究,纳入57例弯曲杆菌属菌血症患者,其中44例血管感染、12例心内膜炎、1例两者兼有;胎儿弯曲杆菌最常见(83%),死亡率为25%,复发率为8%。
要点
- 弯曲杆菌属菌血症患者中血管感染和心内膜炎并不少见,胎儿弯曲杆菌占83%。
- 心血管弯曲杆菌属感染死亡率高达25%,复发率为8%。
- 复发与首次症状后延迟启动有效抗菌治疗、糖尿病及合并骨关节感染相关。
核心结论
- 心血管弯曲杆菌属感染与高死亡率相关。
- 在胎儿弯曲杆菌菌血症病例中,可能有必要系统排查这些感染部位。
研究设计与样本
- 法国全国性5年回顾性研究,纳入57例弯曲杆菌属菌血症患者。
- 其中44例为血管感染,12例为心内膜炎,1例两者兼有。
主要发现
- 胎儿弯曲杆菌是最常见的致病菌种,占83%。
- 抗菌治疗方案中,β-内酰胺单药治疗占54%,联合氟喹诺酮或氨基糖苷类占44%。
- 死亡率为25%,复发率为8%。
- 复发与首次症状后延迟启动有效抗菌治疗、糖尿病以及合并骨关节感染部位相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The incidence of campylobacteriosis has substantially increased over the past decade, notably in France. Secondary localizations complicating invasive infections are poorly described. We aimed to describe vascular infection or endocarditis caused by Campylobacter spp. We included 57 patients from a nationwide 5-year retrospective study on Campylobacter spp. bacteremia conducted in France; 44 patients had vascular infections, 12 had endocarditis, and 1 had both conditions. Campylobacter fetus was the most frequently involved species (83%). Antibiotic treatment involved a β-lactam monotherapy (54%) or was combined with a fluoroquinolone or an aminoglycoside (44%). The mortality rate was 25%. Relapse occurred in 8% of cases and was associated with delayed initiation of an efficient antimicrobial therapy after the first symptoms, diabetes, and coexistence of an osteoarticular location. Cardiovascular Campylobacter spp. infections are associated with a high mortality rate. Systematically searching for those localizations in cases of C. fetus bacteremia may be warranted.
引用
- Tinévez C, Lehours P, Ranc AG, et al. Multicenter Retrospective Study of Vascular Infections and Endocarditis Caused by Campylobacter spp., France. Emerg Infect Dis. 2023. PMID: 36823023. doi:10.3201/eid2903.221417
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。